chrisvoncsefalvay/vaers-outcomes huggingface dataset:
12 hours after the vaccination, 01/29/2021, I woke up and I felt pain below my left eye and it was swollen. I had bubbles on my bottom eyelid or lip of my left eye, right along the edge. I still have a tiny scar on the bottom of my eyelid. A couple of weeks later, starting 02/03/2021, I had extreme abdominal pain, muscle and body aches and cramping, mostly at night, where I couldn't sleep. I felt like I had a wave of cold, metallic, or acid across my chest, I don't know how to describe it, because it's different from what I have ever felt before. I had a telehealth with Dr. on 02/18/2021, and she wanted me to see a gastroenterologist and she prescribed a proton pump inhibitor for 1 month. On 03/10/2021, I went to see the GI doctor. She prescribed doubling the PPI for 30 days and having an upper endoscopy. I followed up with the upper endoscopy on 05/24/2021, even though I was not having the GI problems anymore, the GI doctor wanted me to follow up.
This case was reported by a physician assistant to a sales representative and described an adult subject of unspecified gender who did not respond to immunization to the Engerix-B immunization series. On an unspecified date on or before 09 December 2005, the subject received 3rd dose of Engerix-B. The physician assistant reported to the sales representative that the subject was administered "two pediatric (10 mcg) doses to equal one adult (20 mcg) dose." Approximately 6 weeks after vaccination with the 3rd dose of Engerix-B, on an unspecified date on or before 09 December 2005, a hepatitis B surface antibody titer indicated that the subject was non-immune.
Seen 2/3/12 for headache & delayed immunizations. Received flu vaccine ((L) upper arm), HPV vaccine ((R) upper arm superior aspect) & varicella vaccine ((R) upper middle area). Within 10 - 20 minutes felt itching by varicella vaccine & swelling. Swelling has slightly decreased & itchiness has decreased. Area is not painful except for with palpation. Has not used any meds except for topical hydrocortisone, slightly helpful.
Pt developed erythema, edema, approximately 18 cm circular lesion that was hot to touch and non tender at injection site. Pt was able to bear weight without difficulty.
This case involves 17 years old and unknown gender patient whose physician told that he accidentally gave him Influenza Quadrivalent Recombinant Vaccine [FLUBLOK QIV] with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient received an unknown dose of suspect INFLUENZA QUADRIVALENT RECOMBINANT VACCINE (lot number; formulation; strength: not reported) via unknown route in unknown administration site for prophylactic vaccination (Product administered to patient of inappropriate age; unknown latency). It was reported "Pharmacist states that a Physician told him awhile ago that he accidentally gave a FLUBLOK vaccine to a 17-year-old. He asks if that is acceptable and if there is any reason why pediatrics cannot use FLUBLOK." Action taken with QUADRIVALENT RECOMBINANT INFLUENZA VACCINE (FLUBLOK QIV) was not applicable. At time of reporting, the outcome was Unknown for the event physician told that he accidentally gave a flublok vaccine to a 17 year old with no reported adverse event.
This is the second time I contacted COVID-19 infection. My symptoms started on 02/23/2023. I had severe head congestion, sneezing, fever. blurry eyes, weak, slight cough. and feeling terrible. I did a home test on 02/24/2023 which was positive. The symptoms got worst the next day. I went to the urgent care on 02/26/2023 they tested me for COVID-19 infection which was positive. They prescribe me Paxlovid for 5 days and Nasal spray. I tested 2 weeks later negative on March.
it was administered subcutaneously; she will soon get her second dose of Shingrix; This non-serious case was reported by a consumer via call center representative and described the occurrence of intramuscular formulation administered by other route in a elderly female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix and did not receive the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix and not applicable after receiving Shingrix, the patient experienced intramuscular formulation administered by other route (Verbatim: it was administered subcutaneously) and incomplete course of vaccination (Verbatim: she will soon get her second dose of Shingrix).  The outcome of the intramuscular formulation administered by other route and incomplete course of vaccination were unknown.   Additional Information: GSK Receipt date: 25-AUG-2023 A reporter reported for herself approximately 5 years ago she had her first injection of Shingrix and it was administered subcutaneously which led to Intramuscular formulation administered by other route. The reporter states that she will soon get her second dose of Shingrix. Till the time of reporting the patient had not received the second dose of Shingrix, which led to incomplete course of vaccination. The reporter consented to follow up.
Guillain-Barre syndrome; Initial information received on 07-Dec-2020 regarding an unsolicited valid serious case received from a consumer or non-healthcare professional via social media.  This case is linked to case 2020SA354103 (same reporter).  This case involve female patient (age not reported) who experienced Guillain-Barre Syndrome, while she received vaccine INFLUENZA VACCINE.  The patient's medical history, past medical treatment, vaccination, concomitant medication and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE (produced by unknown manufacturer and lot number not reported) via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed a serious Guillain-Barre Syndrome (unknown latency) following the administration of INFLUENZA VACCINE. This event was assessed as medically significant and was leading to death (Patient was buried on 06-Dec-2020).  Laboratory details were not reported.   It was not reported if the patient received a corrective treatment.  It is unknown if an autopsy was done.   The causes of death was reported as Guillain-Barre Syndrome.  Information on the batch number was requested.; Sender's Comments: This poorly documented social media case concerns a female patient (age not reported) who died due to Guillain-Barre Syndrome after vaccination with INFLUENZA VACCINE (produced by unknown manufacturer). The time to onset was unknown. However, patient's medical condition at the time of vaccination, lab tests ruling out alternate etiologies were not reported. Based upon the reported information, the role of the vaccine cannot be assessed.; Reported Cause(s) of Death: Guillain-Barre syndrome
9 days after  1st dose covid-19 vaccine I developed two 1" diameter hives. one on, and one just below the injection site. itchy red raised welts. arm was hot not terrible itchy, after 8hrs I applied otc Benadryl cream topically. 24 hrs later was red flat and not itchy. redness dissipated over the next day or so
Within 5 minutes of receiving the vaccine my hearing got muffled and my ears began to ring loudly.  For 5 days my ears were ringing so loudly that I could not focus on anything but the ringing. I had trouble hearing and sought medical help. My primary care doctor put me on a five day dose of prednisone. He found no physical reason for the ringing. The prednisone has made it so that the ringing is not the most prominent thing I hear but it is still there and loud.  I will be seeking the help of an audiologist. This week.
Varicella Meningitis w s/s HA, dizziness, disorientation, weakness, photosensitivity, AEB LP results, requiring inpt hospitalization and IV antiviral Rx
Mental Decline. Went into respiratory failure when released from rehab facility.  Also had digestive issues.
Joint pain, unable to raise arm over head, then some improvement, now seeming worse-  pain sleeping on shoulder, pain using shoulder, limited range
This subject is a four month old male, who was admitted to the hospital due to dehydration and gastroenteritis while enrolled in a Phase IV Daptacel P3T07 clinical trial. The subject received three doses of study vaccine; the last dose prior to the event was given on 4/16/03. The subject developed vomiting and profuse diarrhea, 20 days post immunization and was admitted to the hospital the same day. Treatment included IV fluids. The subject improved and was discharged from the hospital two days later. The subject recovered and continued in the trial. The events of dehydration and gastroenteritis were reported by the investigator as unrelated to the study vaccine.
A half an hour after getting the shot, her mouth (and lip) started to swell; A half an hour after getting the shot, her (mouth and) lip started to swell.; This is a spontaneous case from the reported by other non-health professional (consumer) to agency (reference number: SEQ19-03428) and initially received on 27-Sep-2019, concerning a 33-year-old, female patient.     The patient's current conditions included: hypertension, chronic intractable migraines, brain cancer and allergy to suvorexant. The patient's concomitant medications included: metoprolol, Depakote (valproate semisodium), gabapentin, Paxil (piroxicam), memantine, ranitidine, Zyrtec (cetirizine hydrochloride), vitamin D and Emgality (galcanezumab) all for unknown indication and magnesium as supplement.  On 26-Sep-2019 (at 14:00), the patient was administered Afluria Quadrivalent (influenza vaccine, dose: 0.5 ml, anatomical location: left upper arm, batch number reported as B100118555 (Seqirus batch number: P100118555), route of administration and expiration date: not provided) for influenza prophylaxis.  On the same day, half an hour after vaccination, the patient developed mouth and lip swelling. The patient was advised to take Benadryl (diphenhydramine hydrochloride) as a treatment. When the patient's symptoms did not improve,  the patient went to the emergency room, received intravenously solumedrol and got a prescription for prednisone.   On 27-Sep-2019 (at 12:30), the patient recovered from both events.   The case was assessed as serious. The reporter did not provide causality assessment to Afluria Quadrivalent.  Follow up received on 09-Oct-2019: Reporter provided current medical conditions and concomitant medications for the patient. Narrative was amended accordingly.; Sender's Comments: A 33-year-old female patient has experienced mouth swelling and lip swelling half an hour after vaccination with Afluria Quadrivalent. Chronology seems highly suggestive. The patient's historical vaccines included flu shots (without any reaction). Medical history of brain cancer and allergy to suvorexant may have contributed to development of the events. Causality was also confounded by therapy with multiple concomitant drugs.  Considering all the above mentioned, causal role of the suspect product is assessed as possibly related.
This spontaneous report was received from a pharmacist regarding a patient of unknown age and gender. Information on the concurrent condition, medical history and pertinent drug allergies of the patient were not reported. On 23-NOV-2015 at time- 22:59, the patient was vaccinated with improperly stored RECOMBIVAX HB lot # L016427 (expiry date, dose #, route, dose units and anatomical location were not specified). Concomitant medication was not reported. No adverse events were reported. The high temperature and low temperature at which the product was stored were 3.3 and 1.9 (units unspecified) respectively. There were no Product Quality Complaint (PQC) involved. This is one of several reports received from same reporter. Additional information has been requested.
4-5 hrs after vaccine developed headache, fever to 101.8 degrees F and chills. 2-3 watery bowel movements over 24 hrs. Also myalgia. Fever and headache lasted 48 hrs. 24 hrs after injection developed redness at injection.
Moderna vaccine - administered at 4:50pm  Thursday 3/25/21 Tightness of chest at about 35 to 40 minutes post vaccine Itching of face, neck, arms, back, stomach approximately 45 minutes post vaccine, extending to hands and feet around 90 minutes post.  Took 25mg liquid Benadryl at approximately 65 minutes post and 25mg tab at about 120 minutes post.  Friday 3/26/21 - itching, external, internal (bronchial, lungs, trachea) Mild increase in breathing effort (tightness in chest) 25mg Benadryl q8h Stiff arm with pain and swelling  Saturday 3/27/21- same as Friday  Arm pain still present but improved, gone at about 48 hours post but tender to touch.  Sunday 3/28/21 - External itch mild but tolerable Minimal bronchial itching with some chest pressure still present. Pain in arm greatly improved, tender to touch only  Digestive - stomach cramping, moderate nausea, diarrhea, body aches (neck, shoulders, back)  Tightness in chest still present at noon. Took 25mg Benadryl to see if helps.  30 minutes post Benadryl breathing less restricted  Monday 3/29/21 - Breathing easier but lungs feel like I am recovering from several days of coughing.  Breathing ok if I don?t exert myself. Went to pick up Epipen and started with cough by the time I got to the pharmacy counter.   Dr appointment at 12pm
Pt recd vax 23MAY91-25MAY91 t1001. 28MAY91 t100.8 cough, 3JUN91 home fr school for GI upset; 4JUN TC fr mom pt has swollen joints @ knee & elbows 5JUN91 w/swollen joint now has red pinsize spots on legs & some purple spots (size of erasers)
First, let me say that I had a diagnosed case of Coronavirus in April of 2020 last year.  I woke up about 12 hours - at about 3 or 3:30am - after receiving the vaccine to my teeth chattering and feeling like I was freezing.  It felt about the same as it did when I have Coronavirus before.  My head was hurting like a tension headache, I had a slight buzz in my ears, my neck, shoulders, back all hurt (body aches).  I felt pressure in my chest but unlike when I had the virus, I could still breathe.  Eventually instead of freezing, I got hot and my temperature went to 101.9.  I checked it several times with 3 different thermometers.  I became dehydrated quickly which I realized because I kept going to the bathroom.  My niece brought me Gatorade which helped.  I also took Naprxin 500mg.  On Thursday morning I felt better.  Now what remains to oday, Friday, 1/8 is a sore arm that feels HOT to the touch at the injection site.  I admit I am not looking forward to Moderna shot #2.  It gave me flashbacks of the Virus I suffered through for a month before being able to get a test and another month afterward from March 6 when I think I contracted it through May 15 when I tested negative.   I wish I understood why this happened to me and if it will happen again. I am reporting this because my Test was arraigned via my job and my CIO said I should.  A friend who I happened to see at the test site who tested a few patients after me has zero negative effects.
At 8 hours post vaccination, developed gas pains. At 15 hours post vaccination, awakened from sleep with significant gas pains and nausea. At 16 hours post vaccination, vomited. At 17 hours, pain subsided enough to sleep. At 20 hours, awoke feeling mostly normal although with abdominal soreness and fatigue.
8 mm area of tender induration on R thigh with 1/2cm inguinal node.
Raised, Reddened Circular area. Approx 5-6 inches in diameter. Warm to touch.  Sensitive to touch
urticaria Narrative: Body rash-pcp gave prednisone and hydroxyzine
Contracted Covid 10 months after receiving the vaccine. (I was contacted via phone by VAERS; the message said to fill out this form.)
After receiving a Hepatitis A immunization, the client had a vasovagal response and lost consciousness briefly. He also suffered from extreme nausea for approximately an hour. We were concerned primary because most patients receiving this particular vaccine/lot number had at least symptoms of nausea.
Day 3 after shot: intense itching on both arms, chest and lower back. No visible rash. Day 14: itching still present. AND a large, red welt has appeared at the injection site. It is warm, a bit swollen and very tender to the touch.
Pt reports severe left shoulder pain, states IM injection given very "high" feels pain in her shoulder joint suspects given into joint. States was sitting, injector standing. Injection given at downward angle into what appeared the shoulder by spouse (MD) watching. States "needle went completely in and pt is very small, needle came out bent, pt in severe pain with a frozen shoulder" Pt going to see orthopedic for evaluation.
Vaccine side effects included fever, headache, cough, dry throat, muscle pain, joint pain, gastrointestinal distress, abdominal pain, insomnia, arm pain, sweating, chills.
she now had COVID; she did took both the shots; she tested positive; she now had COVID; she did took both the shots; she tested positive; This is a spontaneous report from a Contactable consumer from a Pfizer sponsored program, Pfizer. A female patient of an unspecified age received second dose of bnt162b2 (BNT162B2), via an unspecified route of administration in Mar2021 (Lot number was not reported) as single dose, and first dose via an unspecified route of administration in Feb2021 (Lot number was not reported) as single dose, both for covid-19 immunisation. Medical history and concomitant medications were not reported. It was reported that patient was laying on her back at her home, she took both the shots and she went Monday and get tested and she tested positive and she took shots back in Feb2021 and Mar2021 of the Pfizer vaccine, she now had COVID, onset date 20Sep2021. The patient underwent laboratory tests and procedures which included sars-cov-2 test: positive on 20Sep2021. Outcome of the events was unknown.  The lot number for the vaccine, BNT162B2 was not provided and will be requested during follow-up.
Patient states they feel dizzy, like they have a bad flu (no energy, achy) and they did fall. I advised patient to consult primary care physician.
On night of 14th, had sore throat, cough, chills, fatigue, sneezing.  One night later, had nausea lasting 2 days. On 16th and 21st, saw PMD.  10/22 returned to work.  Throat culture taken but results pending when reported event to me on 10/23.
ON 1/25/21, developed itching and rash at site of injection and down the arm
Pfizer-BioNTech COVID-19 Vaccine EUA  Fatigue and arm soreness within a few hours turned into full body chills, aches, and a fever about 8hrs after injection. Symptoms were intense and lasted throughout the night with Tylenol only minimally reducing fever. All symptoms lasted for about 24hrs, after which I felt completely normal.
about 2 wks p/1st shot had onset of severe projectile vomiting or fever (103-104) lasting 1 day; had same pattern p/2nd shot; had same pattern p/2nd shot; also had onset of frequent, strong flinching spasms of muscles throughtout;
COVID-19; This spontaneous case was reported by a patient and describes the occurrence of COVID-19 (COVID-19) in a 65-year-old male patient who received mRNA-1273 (Spikevax) for COVID-19 prophylaxis.     The patient's past medical history included Leukopenia.    In August 2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 20-Oct-2022, the patient experienced COVID-19 (COVID-19). The patient was treated with NIRMATRELVIR, RITONAVIR (PAXLOVID) from 24-Oct-2022 to 29-Oct-2022 for COVID-19 treatment, at an unspecified dose and frequency. At the time of the report, COVID-19 (COVID-19) had not resolved.        The action taken with mRNA-1273 (Spikevax) (Unknown) was unknown.       No concomitant medications were reported.  The patient's date of birth was reported as Sep-1957.  It was reported that the patient's initial symptom was running nose, that progressed to significant phlegm, minor sore throat, difficult sleep due to congestion when supine and lack of mental clarity for detailed/complex activities.
Pt. has hysterical of atrial fibrillation, which had been successfully controlled for 1yr+3weeks prior to second dose. Pt experienced episode of atrial fibrillation ~2days subsequent to second dose of vaccine.  Pt. spontainiously converted to sinus rhythm ~ 2 weeks later.   Pt. Continued to have episodes of a-fib at increasing intervals and decreasing duration through March (approx 3 mos. after 2nd dose.)   About 4mos. subsequent to 2nd vaccine dose, pt experienced a persistent episode of atrial flutter, which was terminated via electrocardioversion after 4 weeks.
a dose of VARlVAX was administered during a temperature excursion; This spontaneous report has been received from a medical assistant referring to a patient of unknown age and gender. Information about pertinent medical history, concomitant medication or drug reactions/allergies was not provided.  On 21-SEP-2020, the patient was administered with a dose of varicella virus vaccine live (Oka/Merck) (VARIVAX) 0.5 ml; lot # T008129, expiration date 06-MAR-2022 (strength and route were not reported) for prophylaxis during a temperature excursion (product storage error).   The storage temperature of the vaccine was reported as 7.8 Fahrenheit degrees for a time frame of 6 hours and 46 minutes without a data logger. There was no previous temperature excursion. No product quality complaint involved. The outcome of the event was unknown.
Patient initially presented to the outpatient clinic For migraine headache, Frequent Falls and progressive weakness since last 4-5 days. She was managed for PTH independent Hypercalcemia. ED visits and hospital admission within 6 weeks of receiving the COVID vaccine.
pt recv vax 6FEB96 & 8FEB96 pt arm felt bruised @ inj site w/a raised area two inches by on inch, dark pink & warm to touch;pt exp required a MD visit;
Information has been received from a health professional concerning a 26 month old white female with no known allergies or past medical history who on 01/05/00 was vaccinated with Varicella virus vaccine live SQ in the left arm. There were no concomitant medications. On 04/03/01, the patient developed a mild case of the chicken pox, less than 20 pox and no other signs or symptoms and presented to the physician's office on 04/03/01. The child did not have a fever. Additional information is not expected.
This spontaneous report was received from a healthcare worker refers to an unspecified number of patients of unknown age and gender. From an unknown date in February 2014, the patients were vaccinated with VARIVAX (Merck) (strength, dose, route of administration and lot # were not reported). This vaccine was exposed to unknown temperatures. The reporter was not aware of any adverse effects. This is one of several reports received from the same reporter. Additional information has been requested.
I had a fever of 102 for 3 days and pain in vaccination shot. I took TYLENOL for the fever and started to feel better.
a little swelling at injection site; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A female patient received bnt162b2 (BNT162B2), administration date 18Jun2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: VACCINATION SITE SWELLING (non-serious) with onset 02Jul2021, outcome "recovering", described as "a little swelling at injection site".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.